MEDS Old News

MEDSDelisted Stock  USD 7.46  0.56  8.12%   
Slightly above 55% of MEDS Old's private investors are presently thinking to get in. The analysis of current outlook of investing in MEDS Old suggests that some traders are interested regarding MEDS Old's prospects. MEDS Old's investing sentiment can be driven by a variety of factors including economic data, MEDS Old's earnings reports, geopolitical events, and overall market trends.
  
over three months ago at news.google.com         
TRxADE Health, Inc. Announces Name Change to Scienture Holdings, Inc. and Ticker Symbol Change to SC...
Google News at Macroaxis
over three months ago at www.macroaxis.com         
Disposition of tradable shares by Augusta Gary of Trxade subject to Rule 16b-3
Macroaxis News
over three months ago at finance.yahoo.com         
TRxADE Health, Inc. Announces Name Change to Scienture Holdings, Inc.
Yahoo News
over three months ago at kalkinemedia.com         
TinyGemsBreaks TRxAde Health Inc. Changes Name to Scienture Holdings Inc.
news
over three months ago at www.macroaxis.com         
Disposition of tradable shares by Peterson Michael L of Trxade subject to Rule 16b-3
Macroaxis News
over three months ago at globenewswire.com         
TRxADE Health, Inc. Announces New Addition and Changes to Scienture, LLCs Executive Leadership Team
Macroaxis News: globenewswire.com
over three months ago at finance.yahoo.com         
TRxADE Health, Inc. Announces New Addition and Changes to Scienture, LLCs Executive Leadership Team
Yahoo News
over three months ago at thelincolnianonline.com         
Analyzing HWH International and TRxADE HEALTH
news
over three months ago at news.google.com         
Trxade Groups Strategic Merger and Rebranding as Scienture Holdings - TipRanks
Google News at Macroaxis
over three months ago at finance.yahoo.com         
TRxADE Health, Inc. Announces Business Combination with Scienture, Inc., in a Transaction Valued at ...
Yahoo News
over three months ago at globenewswire.com         
TRxADE Health, Inc. Announces Business Combination with Scienture, Inc., in a Transaction Valued at ...
Macroaxis News: globenewswire.com
over three months ago at seekingalpha.com         
Trxade Health acquires Scienture in all-stock transaction valued at 103M
seekingalpha News
over six months ago at bizjournals.com         
Tampa pharma company stacked with former McKesson execs launches IPO
bizjournals News
over six months ago at bizjournals.com         
Discretionary transaction by Narasimhan Mani of 1357538 shares of Trxade subject to Rule 16b-3
bizjournals News
over six months ago at news.google.com         
TRxADE HEALTH, Inc. To Go Ex-Dividend on July 19th - American Banking and Market News
Google News at Macroaxis
Far too much social signal, news, headlines, and media speculation about MEDS Old that are available to investors today. That information is available publicly through MEDS media outlets and privately through word of mouth or via MEDS internal channels. However, regardless of the origin, that massive amount of MEDS data is challenging to quantify into actionable patterns, especially for investors that are not very sophisticated with ever-evolving tools and techniques used in the investment management field.
A primary focus of MEDS Old news analysis is to determine if its current price reflects all relevant headlines and social signals impacting the current market conditions. A news analyst typically looks at the history of MEDS Old relative headlines and hype rather than examining external drivers such as technical or fundamental data. It is believed that price action tends to repeat itself due to investors' collective, patterned thinking related to MEDS Old's headlines and news coverage data. This data is often completely overlooked or insufficiently analyzed for actionable insights to drive MEDS Old alpha.

MEDS Old Performance against Dow Jones

 Price Growth (%)  
       Timeline  
1
Trxade Group declares 1.50 special dividend
07/09/2024
 
MEDS Old dividend paid on 24th of July 2024
07/24/2024
2
Discretionary transaction by Narasimhan Mani of 1357538 shares of Trxade subject to Rule 16b-3
07/25/2024
3
Trxade Health acquires Scienture in all-stock transaction valued at 103M
07/26/2024
4
TRxADE Health, Inc. Announces New Addition and Changes to Scienture, LLCs Executive Leadership Team
08/05/2024
5
TRxADE Health, Inc. Announces Name Change to Scienture Holdings, Inc.
09/20/2024
6
TRxADE Health, Inc. Announces Name Change to Scienture Holdings, Inc. and Ticker Symbol Change to SCNX - StockTitan
09/24/2024
Check out Correlation Analysis to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in unemployment.
You can also try the Sectors module to list of equity sectors categorizing publicly traded companies based on their primary business activities.

Other Consideration for investing in MEDS Stock

If you are still planning to invest in MEDS Old check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the MEDS Old's history and understand the potential risks before investing.
Watchlist Optimization
Optimize watchlists to build efficient portfolios or rebalance existing positions based on the mean-variance optimization algorithm
Options Analysis
Analyze and evaluate options and option chains as a potential hedge for your portfolios
Insider Screener
Find insiders across different sectors to evaluate their impact on performance
My Watchlist Analysis
Analyze my current watchlist and to refresh optimization strategy. Macroaxis watchlist is based on self-learning algorithm to remember stocks you like
Stocks Directory
Find actively traded stocks across global markets
Equity Search
Search for actively traded equities including funds and ETFs from over 30 global markets
Theme Ratings
Determine theme ratings based on digital equity recommendations. Macroaxis theme ratings are based on combination of fundamental analysis and risk-adjusted market performance
Portfolio Analyzer
Portfolio analysis module that provides access to portfolio diagnostics and optimization engine
Investing Opportunities
Build portfolios using our predefined set of ideas and optimize them against your investing preferences